Fri.Nov 10, 2023

article thumbnail

First Vaccine to Prevent Chikungunya Virus Approved by FDA

Drug Topics

Ixchiq contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.

Vaccines 464
article thumbnail

How pharmacy deserts are putting the health of Black and Latino Americans at risk

STAT

Pharmacies were once abundant in the South Side of Chicago. Now, residents living in the majority Black neighborhood often find themselves with few options when it’s time to get a prescription refilled or stock up on cold medicine. Ladell Johnson, a longtime resident of the South Side, drives half an hour from her house to the downtown area every time she needs to pick up her prescription.

Insurance 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Law and Advocacy Update: The Issues Impacting Your Business

Drug Topics

Steve Postal, KD, director of policy and regulatory affairs at the National Community Pharmacists Association, shared an overview of federal- and state-level legislative, advocacy, and regulatory updates.

281
281
article thumbnail

U.K. recommendation could lead to world’s first use of meningitis vaccine to curb gonorrhea

STAT

An expert panel that advises the United Kingdom on vaccine policy has recommended using a meningitis B vaccine to try to bring down spiking rates of gonorrhea. If adopted, the U.K. would be the first country to use the meningitis B vaccine for this purpose. The Joint Committee on Vaccination and Immunization released a report Friday saying that targeted use of a meningitis B vaccine — GSK’s Bexsero — in people at high risk of contracting gonorrhea should reduce the inci

Vaccines 145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Is Your Pharmacy—And Its Technology—Operating at Its Full Potential?

Drug Topics

Stephen Barnes, BA, MA, director of sales and marketing at BestRx Pharmacy Software, discussed the ways that software can optimize a pharmacy's revenue.

247
247
article thumbnail

Opinion: The end of affirmative action means it’s time to revise pre-med requirements

STAT

Luz (not her real name) could be a great doctor. A Latina student from Arizona, she graduated at the top of her high school class and has always aspired to give back to her community. But ultimately, she decided against medical school for one reason: chemistry. It’s not that she isn’t smart enough for chemistry — far from it. She just hates it, finding it dull and unrewarding.

More Trending

article thumbnail

Simultaneous Inhibition of Proteins May Slow Growth of Aggressive, Drug-Resistant Breast Cancer

Pharmacy Times

Researchers determined that simultaneously targeting the BRD4 and LOXL2 proteins disrupts their interaction and inhibits the growth of triple-negative breast cancer cells.

139
139
article thumbnail

Evolving Pharmacy Practice: Embracing a New Paradigm

Drug Topics

Maimuna Bruce, PharmD, MBS, MS, manager of pharmacy advocacy and regulatory affairs at Outcomes, discussed the ways that technology can improve pharmacy workflow.

247
247
article thumbnail

STAT+: What Amazon Prime’s new One Medical offering reveals about the future of health care

STAT

Amazon Prime members have a new offer in addition to the usual delivery and streaming services: Access to One Medical, the Amazon-owned primary care company. Members have the option, announced Wednesday, to pay an additional $9 per month, or $99 per year, for One Medical’s telehealth services and in-office appointments at a discount of about half its typical $199 yearly cost.

Insurance 135
article thumbnail

Roundtable: Let’s Take Back Pharmacy

Drug Topics

Panelists in this round table conversation discuss the opportunities that are available for independent pharmacists to maximize revenue opportunities in their stores.

247
247
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Approves First Vaccine to Prevent Infection from Chikungunya Virus

Pharmacy Times

The vaccine provides treatment prevention for individuals that are high risk of exposure to the chikungunya virus.

Vaccines 132
article thumbnail

Compounded Pilocarpine HCL Solution Found to be Good Alternative to Pilogel Discs

Drug Topics

A study found that the average difference between the pilocarpine HCL solution and Pilogel discs was -3.25 mmol/L and 0.69 mmol/L.

article thumbnail

STAT+: Medicare’s new pay boost for primary care is angering specialists

STAT

WASHINGTON — Doctors are staring down a cut to their Medicare pay next year, and while the news has united them in outrage, it’s also turned one specialty against another. Medicare officials last week announced its major annual update to the way the program pays physicians. Along with other changes, it includes a policy that will boost payments to specialties that rely on evaluating and managing patients, as opposed to those that focus on procedures.

131
131
article thumbnail

5 of the best paid biopharma CEOs

PharmaVoice

As revenue growth remained high last year, so did biopharma CEO pay in the U.S.

130
130
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: EU regulator recommends expanding diabetes drug Mounjaro’s approval to include obesity

STAT

LONDON — Two days after similar decisions in the U.S. and U.K. , regulators in Europe on Friday recommended that the approval of Eli Lilly’s diabetes drug Mounjaro be widened to include obesity.   The ruling from a committee of the European Medicines Agency now goes to the European Commission, which makes the final decision but almost always follows the EMA’s guidance.

Labelling 130
article thumbnail

FDA Approves Prophylactic Treatment for Adults, Pediatric Patients With Extremely Rare Blood-Clotting Disorder

Pharmacy Times

The on-demand enzyme replacement therapy reduced acute thrombotic thrombocytopenic purpura events in patients who experience potentially fatal blood clotting.

FDA 123
article thumbnail

Report: High wait times, poor reimbursement drive autism diagnosis delays

Fierce Healthcare

Nearly two-thirds of specialty centers that conduct autism evaluations have wait times longer than four months, according to a new report. | Nearly two-thirds of specialty centers that conduct autism evaluations have wait times longer than four months, according to a new report.

122
122
article thumbnail

Pharmacy Focus: Psychedelic Pharmacy- Investigating Psilocybin-Assisted Therapy

Pharmacy Times

Jordan Sloshower, MD, MSc, describes his experience working in several clinical trials investigating psilocybin-assisted therapy.

121
121
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Bayer pledges up to $1.5bn for Recursion oncology alliance

pharmaphorum

Bayer pledges up to $1.5bn for Recursion oncology alliance Phil.

116
116
article thumbnail

New method could replace microbiology CFU assay

European Pharmaceutical Review

US researchers have developed the Geometric Viability Assay (GVA), which has been shown to be a fast, cheap and sustainable method for counting microorganisms. Since it is 36 times faster than conventional methods, uses 15 times less plastic, and is low cost, Geometric Viability Assay could “replace existing viability assays and enable viability measurements at previously impractical scales”, the paper noted.

111
111
article thumbnail

Novo Nordisk sets aside $6bn to boost production capacity

pharmaphorum

Novo Nordisk sets aside $6bn to boost production capacity Phil.

111
111
article thumbnail

Novo Nordisk plans multi-billion Denmark manufacturing expansion

European Pharmaceutical Review

Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging. Most of the investment will be focused on API capacity.

Packaging 111
article thumbnail

Takeda gets okay in US for rare blood disorder drug

pharmaphorum

Takeda gets okay in US for rare blood disorder drug Phil.

111
111
article thumbnail

Instacart, Door Dash now allowing users to buy health items using HSAs, FSAs

Fierce Healthcare

As cold and flu season truly sets in, major home delivery platforms are now allowing customers to purchase products using their health benefits. | As cold and flu season truly sets in, major home delivery platforms are now allowing customers to purchase products using their health benefits.

110
110
article thumbnail

First chikungunya vaccine approved by FDA

pharmaphorum

First chikungunya vaccine approved by FDA Phil.

Vaccines 107
article thumbnail

Survey: It's beginning to look like an omnichannel holiday shopping season

Drug Store News

Grocery Doppio's latest survey reveals grocers' holiday prep strategies, including stress testing digital channels, increasing digital promotions and expanding delivery and pick-up options.

107
107
article thumbnail

6 Root Causes Behind Leaky Gut and Autoimmunity

The Thyroid Pharmacist

I often get messages from people with Hashimoto’s and other autoimmune diseases, that say: “Thanks for your efforts, but I’ve already tried everything. I have cut out gluten, dairy, and soy from my diet, and still have Hashimoto’s. How can your work help me?” While changing your diet is an incredibly important first step that will greatly help many of you, if you do not see a complete remission of your symptoms within three to six months, I encourage you to dig deeper.

article thumbnail

FDA approves Takeda’s Adzynma for rare blood clotting disorder

Pharmaceutical Technology

The US FDA has granted approval for Takeda’s Adzynma for congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder.

FDA 105
article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.   That’s right.  Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

104
104
article thumbnail

Happy Veterans Day!

OctariusRx

Happy Veterans Day to all who are serving or have served our country! “We remember those who were called upon to give all a person can give, and we remember those who were prepared to make that sacrifice if it were demanded of them in the line of duty, though it never was. Most of all, we remember the devotion and gallantry with which all of them ennobled their nation as they became champions of a noble cause.” — Ronald Reagan Join the OctariusRx team in giving thanks.

101
101
article thumbnail

AstraZeneca posts 16% drop in Q3 2023 profit after tax

Pharmaceutical Technology

AstraZeneca has posted a profit after tax of $1.37bn for Q3 2023 versus $1.64bn in the same quarter of the previous year, a decline of 16%.

98
article thumbnail

QA/QC & Microbiology In-Depth Focus 2023

European Pharmaceutical Review

Bioburden and sterility testing: how to conserve gene therapy product Kathy Zagaroli, Senior Director of Quality Control at Kiniksa Pharmaceuticals, and Tom Bujold, Senior Director of Quality Control at REGENXBIO, discuss the challenges of bioburden and sterility testing for gene therapies and why industry must come together to drive increased harmonisation.

98
article thumbnail

Schnucks partners with The Salvation Army for annual holiday Tree of Lights campaign

Drug Store News

“Round Up at the Register” will be followed by the return of bell ringers and iconic red kettles.

98